Literature DB >> 35689735

MIR146A and ADIPOQ genetic variants are associated with birth weight in relation to gestational age: a cohort study.

Lívia Reis Silva1, Anderson Sanches Melo1,2, Cristiana Libardi Miranda Furtado3,4,5, Rui Alberto Ferriani1, Karina Bezerra Salomão6, Suleimy Cristina Mazin1, Luiz Gonzaga Tone6, Viviane Cunha Cardoso1, Rosana Maria Dos Reis1.   

Abstract

PURPOSE: To evaluate the genetic variants related to polycystic ovary syndrome (PCOS) and its metabolic complications in girls born small for gestational age (SGA).
DESIGN: Retrospective birth cohort study.
MATERIALS AND METHODS: We evaluated 66 women of reproductive age born at term (37-42 weeks of gestational age) according to the birth weight in relation to gestational age: 26 SGA and 40 AGA (Adequate for gestational age). Anthropometric and biochemical characteristics were measured, as well as the PCOS prevalence. We analyzed 48 single nucleotide polymorphisms (SNPs) previously associated with PCOS and its comorbidities using TaqMan Low-Density Array (TLDA). miRNet and STRING databases were used to predict target and disease networks.
RESULTS: Anthropometric and biochemical characteristics did not differ between the SGA and AGA groups, as well as insulin resistance and PCOS prevalence. Two SNPs were not in Hardy-Weinberg equilibrium, the rs2910164 (MIR146A C > G) and rs182052 (ADIPOQ G > A). The rs2910164 minor allele frequency (MAF) was increased in SGA (OR, 2.77; 95%; CI, 1.22-6.29), while the rs182052 was increased AGA (OR, 0.34; 95%; CI, 0.13 - 0.88). The alleles related to reduced miRNA-146a (C) and ADIPOQ (A) activity showed increased frequency in SGA. The mature miR-146a targets 319 genes, been the CXCR4, TMEM167A and IF144L common targets and contributes to PCOS. The ADIPOQ main protein interactions were ERP44, PPARGCIA and CDH13.
CONCLUSIONS: The miR-146a (rs2910164) and ADIPOQ (rs182052) allelic variants are related to birth weight in SGA and may predict health-related outcomes, such as PCOS and obesity risk.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adiponectin; Maternal–fetal interaction; Micro-RNAs; Single nucleotide polymorphisms; Small for gestational age

Mesh:

Substances:

Year:  2022        PMID: 35689735      PMCID: PMC9428086          DOI: 10.1007/s10815-022-02532-x

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  68 in total

1.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma.

Authors:  Krystian Jazdzewski; Elizabeth L Murray; Kaarle Franssila; Barbara Jarzab; Daniel R Schoenberg; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

Review 2.  A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases.

Authors:  Seyed Shahabeddin Mortazavi-Jahromi; Mona Aslani; Abbas Mirshafiey
Journal:  Immunol Lett       Date:  2020-08-15       Impact factor: 3.685

3.  Association of adiponectin polymorphism with cord blood adiponectin concentrations and intrauterine growth.

Authors:  Makoto Saito; Tomohiro Kamoda; Kazunori Nishimura; Yayoi Miyazono; Yu Kanai; Yoshiaki Kato; Atsushi Iwabuchi; Hiroko Fukushima; Hiromi Hamada; Tadao Arinami; Ryo Sumazaki; Emiko Noguchi
Journal:  J Hum Genet       Date:  2011-11-24       Impact factor: 3.172

4.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

Authors:  Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies
Journal:  Hum Reprod       Date:  2009-11-12       Impact factor: 6.918

Review 5.  Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.

Authors:  H Teede; A Deeks; L Moran
Journal:  BMC Med       Date:  2010-06-30       Impact factor: 8.775

Review 6.  Association of MiR-146a Expression and Type 2 Diabetes Mellitus: A Meta-Analysis.

Authors:  Behnam Alipoor; Hamid Ghaedi; Reza Meshkani; Shahram Torkamandi; Sana Saffari; Mostafa Iranpour; Mir Davood Omrani
Journal:  Int J Mol Cell Med       Date:  2017-08-14

Review 7.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.

Authors:  Jacob O'Brien; Heyam Hayder; Yara Zayed; Chun Peng
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-03       Impact factor: 5.555

8.  MiR-146a is over-expressed and controls IL-6 production in cystic fibrosis macrophages.

Authors:  Francesco R Luly; Manuella Lévêque; Valerio Licursi; Giuseppe Cimino; Corinne Martin-Chouly; Nathalie Théret; Rodolfo Negri; Luca Cavinato; Fiorentina Ascenzioni; Paola Del Porto
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

9.  MicroRNA-146a limits tumorigenic inflammation in colorectal cancer.

Authors:  Amrendra K Ajay; Mai Fujiwara; Lucien P Garo; Galina Gabriely; Radhika Raheja; Chantal Kuhn; Brendan Kenyon; Nathaniel Skillin; Ryoko Kadowaki-Saga; Shrishti Saxena; Gopal Murugaiyan
Journal:  Nat Commun       Date:  2021-04-23       Impact factor: 14.919

10.  New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism.

Authors:  Momoko Horikoshi; Hanieh Yaghootkar; Dennis O Mook-Kanamori; Ulla Sovio; H Rob Taal; Branwen J Hennig; Jonathan P Bradfield; Beate St Pourcain; David M Evans; Pimphen Charoen; Marika Kaakinen; Diana L Cousminer; Terho Lehtimäki; Eskil Kreiner-Møller; Nicole M Warrington; Mariona Bustamante; Bjarke Feenstra; Diane J Berry; Elisabeth Thiering; Thiemo Pfab; Sheila J Barton; Beverley M Shields; Marjan Kerkhof; Elisabeth M van Leeuwen; Anthony J Fulford; Zoltán Kutalik; Jing Hua Zhao; Marcel den Hoed; Anubha Mahajan; Virpi Lindi; Liang-Kee Goh; Jouke-Jan Hottenga; Ying Wu; Olli T Raitakari; Marie N Harder; Aline Meirhaeghe; Ioanna Ntalla; Rany M Salem; Karen A Jameson; Kaixin Zhou; Dorota M Monies; Vasiliki Lagou; Mirna Kirin; Jani Heikkinen; Linda S Adair; Fowzan S Alkuraya; Ali Al-Odaib; Philippe Amouyel; Ehm Astrid Andersson; Amanda J Bennett; Alexandra I F Blakemore; Jessica L Buxton; Jean Dallongeville; Shikta Das; Eco J C de Geus; Xavier Estivill; Claudia Flexeder; Philippe Froguel; Frank Geller; Keith M Godfrey; Frédéric Gottrand; Christopher J Groves; Torben Hansen; Joel N Hirschhorn; Albert Hofman; Mads V Hollegaard; David M Hougaard; Elina Hyppönen; Hazel M Inskip; Aaron Isaacs; Torben Jørgensen; Christina Kanaka-Gantenbein; John P Kemp; Wieland Kiess; Tuomas O Kilpeläinen; Norman Klopp; Bridget A Knight; Christopher W Kuzawa; George McMahon; John P Newnham; Harri Niinikoski; Ben A Oostra; Louise Pedersen; Dirkje S Postma; Susan M Ring; Fernando Rivadeneira; Neil R Robertson; Sylvain Sebert; Olli Simell; Torsten Slowinski; Carla M T Tiesler; Anke Tönjes; Allan Vaag; Jorma S Viikari; Jacqueline M Vink; Nadja Hawwa Vissing; Nicholas J Wareham; Gonneke Willemsen; Daniel R Witte; Haitao Zhang; Jianhua Zhao; James F Wilson; Michael Stumvoll; Andrew M Prentice; Brian F Meyer; Ewan R Pearson; Colin A G Boreham; Cyrus Cooper; Matthew W Gillman; George V Dedoussis; Luis A Moreno; Oluf Pedersen; Maiju Saarinen; Karen L Mohlke; Dorret I Boomsma; Seang-Mei Saw; Timo A Lakka; Antje Körner; Ruth J F Loos; Ken K Ong; Peter Vollenweider; Cornelia M van Duijn; Gerard H Koppelman; Andrew T Hattersley; John W Holloway; Berthold Hocher; Joachim Heinrich; Chris Power; Mads Melbye; Mònica Guxens; Craig E Pennell; Klaus Bønnelykke; Hans Bisgaard; Johan G Eriksson; Elisabeth Widén; Hakon Hakonarson; André G Uitterlinden; Anneli Pouta; Debbie A Lawlor; George Davey Smith; Timothy M Frayling; Mark I McCarthy; Struan F A Grant; Vincent W V Jaddoe; Marjo-Riitta Jarvelin; Nicholas J Timpson; Inga Prokopenko; Rachel M Freathy
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.